Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Barbarot

Showing results (131-140 of 164) with videos related to

Pageof 17
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|June 8, 2018
Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part IIA Wollenberg, S Barbarot, T Bieber, et al.
Annales De Dermatologie Et De Venereologie|February 8, 2021
Acute acral eruptions in children during the COVID-19 pandemic: Characteristics of 103 children and their family clustersT Hubiche, A Phan, S Leducq, et al.
The British Journal of Dermatology|February 6, 2019
TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registriesF M Vermeulen, L A A Gerbens, A L Bosma, et al.
The British Journal of Dermatology|May 16, 2018
TREatment of ATopic eczema (TREAT) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo- and systemic therapy registriesL A A Gerbens, C J Apfelbacher, A D Irvine, et al.
The British Journal of Dermatology|July 7, 2020
Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testingL Le Cleach, L Dousset, H Assier, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 6, 2019
Defining and measuring 'eczema control': an international qualitative study to explore the views of those living with and treating atopic eczemaL Howells, K S Thomas, A V Sears, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 14, 2017
Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohortE Sbidian, C Giboin, H Bachelez, et al.
Annales De Dermatologie Et De Venereologie|March 13, 2016
[Impact of sex and age on the clinical and epidemiological aspects of childhood psoriasis: Data from a French cross-sectional multicentre study]J Bonigen, A Phan, S Hadj-Rabia, et al.
The British Journal of Dermatology|November 8, 2021
Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practiceM-E Marniquet, J Seneschal, A-S Darrigade, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2022
Effectiveness and safety of dupilumab in the treatment of atopic dermatitis in children (6-11 years): data from a French multicentre retrospective cohort in daily practiceA Lasek, N Bellon, S Mallet, et al.
Pageof 17

Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
Journal of the European Academy of Dermatology and Venereology : JEADV|June 8, 2018
Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part IIA Wollenberg, S Barbarot, T Bieber, et al.
Annales De Dermatologie Et De Venereologie|February 8, 2021
Acute acral eruptions in children during the COVID-19 pandemic: Characteristics of 103 children and their family clustersT Hubiche, A Phan, S Leducq, et al.
The British Journal of Dermatology|February 6, 2019
TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registriesF M Vermeulen, L A A Gerbens, A L Bosma, et al.
The British Journal of Dermatology|May 16, 2018
TREatment of ATopic eczema (TREAT) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo- and systemic therapy registriesL A A Gerbens, C J Apfelbacher, A D Irvine, et al.
The British Journal of Dermatology|July 7, 2020
Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testingL Le Cleach, L Dousset, H Assier, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 6, 2019
Defining and measuring 'eczema control': an international qualitative study to explore the views of those living with and treating atopic eczemaL Howells, K S Thomas, A V Sears, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 14, 2017
Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohortE Sbidian, C Giboin, H Bachelez, et al.
Annales De Dermatologie Et De Venereologie|March 13, 2016
[Impact of sex and age on the clinical and epidemiological aspects of childhood psoriasis: Data from a French cross-sectional multicentre study]J Bonigen, A Phan, S Hadj-Rabia, et al.
The British Journal of Dermatology|November 8, 2021
Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practiceM-E Marniquet, J Seneschal, A-S Darrigade, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2022
Effectiveness and safety of dupilumab in the treatment of atopic dermatitis in children (6-11 years): data from a French multicentre retrospective cohort in daily practiceA Lasek, N Bellon, S Mallet, et al.
Pageof 17